The power and pitfalls of omics part 2: epigenomics, transcriptomics and ME/CFS
Simon McGrath concludes his blog about the remarkable Prof George Davey Smith's smart ideas for understanding diseases, which may soon be applied to ME/CFS.
Discuss the article on the Forums.

Paper on therapeutic allegiance of researchers affecting RCT results

Discussion in 'Other Health News and Research' started by Esther12, Aug 5, 2012.

  1. Esther12

    Esther12 Senior Member

    free full paper here:

    I got a bit tired toward the end, but tried to pull out the bits which would be key to assessing the value of CBT/GET for CFS.

    I've started looking more generally at the extent to which psychological interventions can be seen as 'placebo', and the extent to which 'placebo' can mean simply patients wanting to be polite and positive in questionnaires about those who have tried to help them, rather than the patients themselves seeing any significant improvement in their health problems. It seems like a lot of psychiatrists/therapists/etc see themselves as providing little more than placebo, but think that this is a wonderful and life changing thing. I'm not sure how evidence based this view is.

    Does anyone know whether the PACE researchers had any prior allegiance to any of the different treatments being assessed?

    Ho ho.

See more popular forum discussions.

Share This Page